122 related articles for article (PubMed ID: 29218693)
1. Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.
Fanelli M; Camperchioli A; Petrella L; Petrillo M; Baranello C; Baccaro P; Paolillo C; Capoluongo E; Scambia G
Int J Biol Markers; 2018 Jan; 33(1):124-131. PubMed ID: 29218693
[TBL] [Abstract][Full Text] [Related]
2. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
Wang Y; Li L; Guo X; Jin X; Sun W; Zhang X; Xu RC
Cytokine; 2012 Aug; 59(2):228-36. PubMed ID: 22595649
[TBL] [Abstract][Full Text] [Related]
5. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion.
Wang Y; Xu RC; Zhang XL; Niu XL; Qu Y; Li LZ; Meng XY
Cytokine; 2012 Jul; 59(1):145-55. PubMed ID: 22579115
[TBL] [Abstract][Full Text] [Related]
7. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
Miao F; Zhang X; Cao Y; Wang Y; Zhang X
BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
[TBL] [Abstract][Full Text] [Related]
8. [CBL inhibits proliferation and invasion of breast cancer cells by ubiquitylation-mediated degradation of NCK2].
Song X; Xiao B; Lu J; Zhang W; Li J; Zhu X; Sun Z; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1594-1603. PubMed ID: 36504051
[TBL] [Abstract][Full Text] [Related]
9. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
Law AY; Wong CK
Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
[TBL] [Abstract][Full Text] [Related]
10. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
11. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
12. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
Chen Z; Fadiel A; Feng Y; Ohtani K; Rutherford T; Naftolin F
Cancer; 2001 Dec; 92(12):3068-75. PubMed ID: 11753986
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures.
Rossow L; Eke I; Dickreuter E; Cordes N
Oncol Rep; 2015 Jul; 34(1):469-76. PubMed ID: 26004008
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Zhang L; Zou W
Mol Med Rep; 2015 Dec; 12(6):7869-76. PubMed ID: 26497667
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma.
Hu Y; Li Y; Wu C; Zhou L; Han X; Wang Q; Xie X; Zhou Y; Du Z
Tumour Biol; 2017 Apr; 39(4):1010428317697558. PubMed ID: 28443475
[TBL] [Abstract][Full Text] [Related]
16. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4.
Chen S; Guan X; Wang LL; Li B; Sang XB; Liu Y; Zhao Y
Gene; 2017 Nov; 635():3-8. PubMed ID: 28888575
[TBL] [Abstract][Full Text] [Related]
17. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 is related to tumor progression in ovarian cancer.
Zhang J; Liu L; Han S; Li Y; Qian Q; Zhang Q; Zhang H; Yang Z; Zhang Y
Oncol Rep; 2017 Oct; 38(4):2426-2434. PubMed ID: 28765941
[TBL] [Abstract][Full Text] [Related]
19. Targeting ILK and β4 integrin abrogates the invasive potential of ovarian cancer.
Choi YP; Kim BG; Gao MQ; Kang S; Cho NH
Biochem Biophys Res Commun; 2012 Oct; 427(3):642-8. PubMed ID: 23026047
[TBL] [Abstract][Full Text] [Related]
20. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.
Chen SW; Zhang Q; Xu ZF; Wang HP; Shi Y; Xu F; Zhang WJ; Wang P; Li Y
Mol Med Rep; 2016 Oct; 14(4):3261-8. PubMed ID: 27573865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
